Catalyst Pharmaceuticals Inc

Catalyst Pharmaceuticals Inc

CPRX

Market Cap$2.97B
Close$

Compare to Similar Companies

P/E RatioDividendsReturn on EquityPrice-to-SalesDebt-to-Equity
Catalyst Pharmaceuticals IncCatalyst Pharmaceuticals Inc15-18%8.1-
$30.00

Target Price by Analysts

23.1% upsideCatalyst Pharmaceuticals Target Price DetailsTarget Price
$16.80

Current Fair Value

31.1% downside

Overvalued by 31.1% based on the discounted cash flow analysis.

Share Statistics

Market cap$2.97 Billion
Enterprise Value$2.41 Billion
Dividend Yield$0 (0%)
Earnings per Share$1.38
Beta0.7
Outstanding Shares121,472,468

Return

Return on Equity-
Return on Assets-
Return on Invested Capital-

Valuation & Multiples

P/E Ratio15
PEG-6.18
Price to Sales8.12
Price to Book Ratio4.06
Enterprise Value to Revenue5.25
Enterprise Value to EBIT13.83
Enterprise Value to Net Income16
Total Debt to Enterprise0.01
Debt to Equity0.02

Revenue Sources

No data

Insider Trades

ESG Score

No data

About Catalyst Pharmaceuticals Inc

CEO: Patrick McEnany